September 21, 2023
Ron Alterovitz, PhD, in the UNC Computer Science Department, and Jason Akulian, MD MPH, in the UNC School of Medicine, have shown that their steerable lung robot can autonomously maneuver the intricacies of the lung, while avoiding important lung structures.
September 12, 2023
A phase 2 study, led by Thomas W. Ferkol, MD, at the UNC School of Medicine, demonstrates safety and efficacy of idrevloride with hypertonic saline for treatment of primary ciliary dyskinesia, a rare genetic disorder that can lead to permanent lung damage.
July 19, 2023
Ilona Jaspers, PhD, director of the UNC Center for Environmental Medicine, Asthma, and Lung Biology, co-authored a study with colleagues from the UNC Gillings School of Global Public Health and the U.S. Environmental Protection Agency on possible effects of wildfire smoke in-utero or in the first weeks of life.
July 11, 2023
Springer recently released "Chronic Illness Care, Principles and Practice," edited by UNC Family Medicine's Timothy P. Daaleman, DO, MPH, and Margaret R. Helton, MD. Faculty members in the Department of Family Medicine, faculty across the UNC-Chapel Hill campus, and other national and international experts wrote the textbook.
January 3, 2023
Meghan Rebuli, PhD, an assistant professor of pediatrics in the UNC School of Medicine and member of the Center for Environmental Medicine, Asthma, and Lung Biology, shares new findings and recommendations from an expert-led workshop.
June 30, 2022
With the FDA ordering Juul to stop selling their e-cigarette devices, UNC School of Medicine researchers led by Ilona Jaspers, PhD, published the first study to compare the respiratory immune health effects of different types of devices.
April 29, 2022
James S. Hagood, MD, professor in the UNC Department of Pediatrics and Director of the Program for Rare and Interstitial Lung Disease of the UNC Children’s Research Institute and Marsico Lung Institute, has been selected as a Harrington Scholar-Innovator for his work on a therapeutic Strategy for pulmonary fibrosis.
April 5, 2022
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new checkpoint that cells use to control what molecules they internalize. Understanding the determinants for entry into cells could lead to the design of better therapeutics that must enter through this gatekeeping mechanism.
March 1, 2022
The Translational Team Science Awards program is aimed at capitalizing on UNC-Chapel Hill’s culture of collaboration and fostering interdisciplinary teams of basic science and clinical investigators.
January 31, 2022
The UNC Center for Environmental Medicine, Asthma, and Lung Biology, led by Ilona Jaspers, PhD, was awarded an EPA cooperative agreement for $4.5 million over three years.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
November 8, 2021
Jim Hagood, MD, Professor of Pediatrics, and Ronit Freeman, PhD, Associate Professor in Applied Physical Science, have been awarded a grant by Eshelman Institute for Innovation to pursue research in lung fibrosis.